Kouichi Hasegawa
Overview
Explore the profile of Kouichi Hasegawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
863
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ghazimoradi M, Hasegawa K, Zolghadr E, Montazeri S, Farivar S
Sci Rep
. 2023 Jan;
13(1):1154.
PMID: 36670207
Many attempts have been made to induce high-quality embryonic stem cells such as pluripotent stem cells and totipotent stem cells, but challenges remain to be overcome such as appropriate methods...
2.
Hasegawa K, Fujimoto T, Mita C, Furumoto H, Inoue M, Ikegami K, et al.
Lasers Surg Med
. 2022 Aug;
54(8):1167-1176.
PMID: 35916125
Objectives: Hair loss, including alopecia, is a common dermatological issue worldwide. At present, the application of fractional carbon dioxide (CO ) laser in the treatment of alopecia has been documented;...
3.
Etezadi F, Le M, Shahsavarani H, Alipour A, Moazzezy N, Samani S, et al.
ACS Biomater Sci Eng
. 2022 Apr;
8(5):2040-2052.
PMID: 35468288
Despite the numerous advantages of PDMS-based substrates in various biomedical applications, they are limited by their highly hydrophobic surface that does not optimally interact with cells for attachment and growth....
4.
Endo Y, Kamei K, Hasegawa K, Okita K, Ito H, Terada S, et al.
Stem Cells Dev
. 2022 Mar;
31(9-10):250-257.
PMID: 35316100
Induced pluripotent stem cells (iPSCs) can serve as a biological resource for functional and conservation research for various species. This realization has led to the generation of iPSCs from many...
5.
Shimizu E, Iguchi H, Le M, Nakamura Y, Kobayashi D, Arai Y, et al.
Sci Rep
. 2022 Feb;
12(1):2516.
PMID: 35169157
Clinical use of human pluripotent stem cells (hPSCs) is hampered by the technical limitations of their expansion. Here, we developed a chemically synthetic culture substrate for human pluripotent stem cell...
6.
Wong R, Hasegawa K, Peh G, Liu G
Front Cell Neurosci
. 2021 Dec;
15:794010.
PMID: 34867209
No abstract available.
7.
Pillai S, Borah A, Le M, Kawano H, Hasegawa K, Kumar D
Pharmaceutics
. 2021 Sep;
13(9).
PMID: 34575496
Cholesterol-rich arterial plaques characterize atherosclerosis, a significant cause of heart disease. Nutraceuticals have received attention over the years, demonstrating potential benefits towards treating and preventing cardiovascular diseases (CVD), including atherosclerosis....
8.
Kafer G, Tanaka Y, Rillo-Bohn R, Shimizu E, Hasegawa K, Carlton P
J Cell Sci
. 2020 Nov;
133(24).
PMID: 33199519
During the transition from pluripotency to a lineage-committed state, chromatin undergoes large-scale changes in structure, involving covalent modification of histone tails, use of histone variants and gene position changes with...
9.
Hosseini V, Kalantary-Charvadeh A, Hasegawa K, Ahmad S, Rahbarghazi R, Mahdizadeh A, et al.
Mol Biol Rep
. 2020 Nov;
47(11):8881-8890.
PMID: 33130988
Mouse embryonic fibroblasts (MEFs) accessibility coupled with their simple generation make them as a typical embryonic cell model and feeder layer for in vitro expansion of pluripotent stem cells (PSCs)....
10.
Subramani P, Vartak-Sharma N, Sreekumar S, Mathur P, Nayer B, Dakhore S, et al.
Malar J
. 2020 Jun;
19(1):214.
PMID: 32571333
Background: Vivax malaria is associated with significant morbidity and economic loss, and constitutes the bulk of malaria cases in large parts of Asia and South America as well as recent...